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Objectives: The general consensus is that surgical treatment is advisedwhen conser-
vative methods fail in patients with lumbosacral radicular syndrome (LRS). Preliminary
evidence from our pilot study indicates that combination therapy (mechanical diagnosis
therapy and transforaminal epidural injections) can prevent surgical treatment in
patients on the waiting list for surgery. The pilot study lacked a control group, and
therefore, firm conclusions pertaining to effects could not be made. This study aims
to determine if combination therapy, performed while being on the waiting list for lum-
bar herniated disc surgery, is effective and cost‐effective comparedwith usual care (i.e.,
no intervention while being on the waiting list) among patients with a magnetic reso-
nance imaging (MRI)‐confirmed indication for a lumbar herniated disc surgery.
Methods: A randomized controlled trial will be conducted with an economic evalua-
tion. Patients aged 18 and above with incapacitating LRS, with leg pain and an MRI
confirmed indication for lumbar disc hernia surgery, will be recruited from seven Dutch
hospitals.While being on the waiting list for lumbar herniated disc surgery, patients will
be randomized to either the combination therapy or usual care group. The primary out-
come measure is the number of patients undergoing lumbar disc surgery during
12‐month follow‐up. Secondary outcomes include back and leg pain intensity (numeric
pain rating scale), physical functioning (Roland Morris Disability Questionnaires‐23),
self‐perceived recovery (global perceived effect), and health‐related quality of life
(EuroQol Five Dimensions Health Questionnaire (EQ‐5D‐5L) and 12‐Item Short Form
Health Survey (SF‐12)). For the economic evaluation, societal and health care costs will
be measured. Measurements moments are baseline, 1, 2, 4, 6, 9, and 12 months. Data
will be analysed according to the intention‐to‐treat principle.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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2 of 8 MUTUBUKI ET AL.Conclusion: No randomized controlled trials have evaluated the effectiveness and
cost‐effectiveness of combination therapy compared with usual care in patients with
an indication for lumbar herniated disc surgery, which emphasizes the importance of
this study.
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Lumbar disc herniation is the most common cause of lumbosacral
radicular syndrome (LRS), also known as sciatica. Characteristics of
LRS include radiating lower limb pain into a particular dermatome,
which may be accompanied by sensory and or motor deficits
(Oosterhuis et al., 2014). Evidence suggests that the pathophysiology
of LRS is not attributed to just pressure on the nerve roots but to a
complex interplay of inflammatory, immunological, and pressure
related processes (Stafford, Peng, & Hill, 2007). Estimated LRS inci-
dence rate in Western countries is 5 per 1,000 (Cherkin, Deyo, Loeser,
Bush, & Waddell, 1994). In the Netherlands, the incidence rate of LRS
in general practice is 12 per 1,000 patients per year (Schaafstra et al.,
2015). The yearly direct and indirect costs of LRS are high and esti-
mated to be €1.2 billion in the Netherlands (Health Council of the
Netherlands, 1999).
There is a lot of variation in LRS prevalence in literature
(Konstantinou&Dunn, 2008). Consequently, there are disparities in spi-
nal surgery rates regionally and internationally (Weinstein, Lurie, Olson,
Bronner, & Fisher, 2006). In the United States, spinal surgery rates are
30% higher than in the Netherlands, 80% higher than in United
Kingdom, and 50–60% higher than in Canada (Cherkin et al., 1994).
The Dutch guideline “Lumbosacral Radicular Syndrome” recom-
mends surgical treatment if the radiating leg pain persists following con-
servative management (Kwaliteitsinstituut voor de Gezondheidszorg
CBO, 2008). A significant number of patients undergoing surgery for
lumbar disc herniation suffer residual complaints. Recovery rates in
the literature vary wildly. Recent figures from the Netherlands suggest
a rate between 69% and 79% after 2‐year follow‐up, and 10%–15% of
the patients need repeated surgery, the majority of which were due to
recurrent disc herniation at the same level (Arts et al., 2011). Findings
of Peul et al. (2007) indicate that surgical and nonsurgical management
of lumbar hernia are equally successful in the long term.
Both mechanical diagnosis and treatment (MDT) and
transforaminal epidural steroid injections (TESIs) are reported to be
individually effective in reducing pain and improving function among
LRS patients (Chou et al., 2015; van Helvoirt et al., 2014). Epidural
corticosteroid injections for radiculopathy are associated with imme-
diate reduction in pain (Chou et al., 2015). TESIs are indicated in
LRS, and the role of physiotherapy, possibly in combination with
TESIs, should be further explored (Kwaliteitsinstituut voor de
Gezondheidszorg CBO, 2008). None of the randomized controlled
trials included by Chou et al. (2015) combined TESIs with MDT.The only two publications that we identified assessing a combination
therapy of TESIs and MDT were our own pilot study (van Helvoirt
et al., 2014), and a report on three cases of acute cervical
radiculopathy (Desai, Padmanabhan, Simbasivan, Kamanga‐Sollo, &
Dharmappa, 2012). Our pilot study suggests that combining these
interventions has the potential to reduce the number of lumbar her-
niated disc surgeries, as only 22% of patients with a herniated lum-
bar disc still needed surgery after 1‐year follow‐up (van Helvoirt
et al., 2014).
Research indicates that the effects of lumbar disc surgery are com-
parable with those of conservative treatment after 1 and 2 years (Peul
et al., 2007; Peul et al., 2008). Clinical guidelines prescribe shared deci-
sion making and that pros and cons of both options should be
discussed with patients (Kwaliteitsinstituut voor de Gezondheidszorg
CBO, 2008; National Institute for Health and Clinical Excellence,
2016). Surgery is costly and potentially causes various side effects
(e.g., nerve root damage, infection, and pain that continues after sur-
gery); hence, spinal surgeons typically aim to prolong conservative
therapy. Physiotherapists could play an important role in preventing
surgery if they combine their treatment with optimal pain manage-
ment (Schaafstra et al., 2015). Although the results from our pilot
study seem to be promising, the effectiveness and cost‐effectiveness
of a combination therapy of TESIs and MDT have not been rigorously
evaluated. Therefore, this study aims to determine if a combination
therapy, while being on the waiting list for a lumbar herniated disc sur-
gery, is effective and cost‐effective compared with usual care (i.e., no
intervention while being on the waiting list) among patients with a
magnetic resonance imaging‐confirmed indication for a lumbar herni-
ated disc surgery.
2 | METHODS
2.1 | Study design
A multicentre randomized controlled trial with a 12‐month follow‐up
and a full economic evaluation.
2.1.1 | Ethical approval
In September 2017, the Medical Ethics Committee of the VU Univer-
sity Medical Centre Amsterdam approved the study protocol, registra-
tion Number NL60558.029.17 and the study was registered in the
Dutch Trial Register NTR6715.
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2.2.1 | Inclusion criteria
Inclusion criteria are as follows: patients aged 18 and above; eligibil-
ity for lumbar disc hernia surgery; incapacitating LRS with leg pain
(numeric pain rating scale [NPRS] > 6; with or without back pain)
that had lasted for a minimum of 6 weeks with or without mild neu-
rological deficit (i.e., Medical Research Council > 3); and a magnetic
resonance imaging that confirms a hernia nuclei pulposi that com-
promises the spinal nerve and can explain the clinical symptoms of
the patient.2.2.2 | Exclusion criteria
Exclusion criteria are as follows: spine surgery and or transforaminal
injections at the same level during the previous 6 months; bony ste-
nosis; cauda equina syndrome; spondylolisthesis; pregnancy; compli-
cated disc herniation requiring more than one operation; severe
coexisting disease (e.g., osteoporosis and dementia); patient with
contraindications for steroid injections; insufficient knowledge of
the Dutch language; emergency surgery as determined by the neuro-
surgeon; and being allergic for Iohexol 240 mg/ml (i.e., OMNIPAQUE
240).FIGURE 1 Flow chart of the Preventing
lumbar disc surgery (PLUS) study2.2.3 | Patient recruitment
Figure 1 shows the flow diagram of the study. Neurosurgeons or
orthopaedic surgeons of the participating hospitals recruit and
inform the patients about the study and the possibility to participate
while they are on the waiting list for surgery. The surgeon then
refers the patient to the research team who will check if the patient
meets the aforementioned inclusion and exclusion criteria. If the
patient is eligible and gives informed consent, the patient will be
included in this study. Baseline measures will then be made and
patients will be randomized to either the intervention or the control
arm of the study.
2.2.4 | Setting
Participants will be recruited from seven hospitals in the Nether-
lands. The hospitals were chosen due to their proximity to the four
primary care‐based outpatient clinics (so‐called “Rugpoli's”) where
the combination therapy will be provided.
2.3 | Materials
2.3.1 | Prognostic factors
Prognostic factors measured at baseline using an online questionnaire
include duration and severity of complaints before operation, various
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confounding factors such as age, gender, educational level, and treat-
ment expectation (Kwaliteitsinstituut voor de Gezondheidszorg CBO,
2008).
2.3.2 | Primary outcomes measure
The primary outcome measure is the proportion of LRS patients
undergoing lumbar disc surgery during 12‐month follow‐up. Patients
will be scored as either having had a lumbar surgery or not. For this
purpose, patients will be asked whether they had a lumbar surgery
during the previous weeks following the last assessment, using an
online questionnaire at 2, 4, 6, 9, and 12 months after randomization,
and validated using hospital records.
2.3.3 | Secondary outcomes measures
In line with the core outcome set for clinical research and clinical
practice (Chiarotto et al., 2018), secondary study parameters include
back and leg pain, physical functioning, and health‐related quality of
life. Additionally, we will measure self‐perceived recovery, patient
satisfaction (single question), and pain location (pain mannequin).
Measurements will take place at baseline, 2, 4, 6, 9, and 12 months
after randomization and administered through online questionnaires.
An additional pain intensity measurement will be carried out at
4 weeks after randomization. The rationale is that, especially leg pain,
will improve in the combination group. Complications will be noted
in a case report form. Societal and health care costs will be estimated
for economic evaluation using resource use data, collected through
online questionnaires at baseline, 2, 4, 6, 9, and 12 months after
randomization.
Back and leg pain will be measured using the NPRS
The NPRS ranges from 0 (“no pain”) to 10 (“representing worst pain
imaginable”). The numerical pain rating scale is reliable, valid, and has
good sensitivity (Williamson & Hoggart, 2005).
Functional status will be measured with Roland Morris Disabil-
ity Questionnaires
Five Roland Morris Disability Questionnaires (RMDQ‐24) items were
removed and four new items were added from the initial source of
RMDQ items, to create RMDQ‐23 (Bergner, Bobbitt, Carter, & Gilson,
1981). RMDQ‐23 consists of 23 “yes” or “no” questions, measuring
limitation in activity associated with back and leg pain (Kent, Grotle,
Dunn, Albert, & Lauridsen, 2015). The scores can range from 0 (no dis-
ability) to 23 (maximal disability). It has been extensively used in
radiculopathy and stenosis research as a standardized measure and is
widely used to assess disability specific to back and leg pain making
it suitable people with LRS (Kent et al., 2015). The RMDQ‐23 is
regarded as reliable and valid (Yamato, Maher, Saragiotto, Catley, &
McAuley, 2017). It has been translated into Dutch.
Health‐related quality of life (EQ‐5D‐5L and SF‐12)
The EQ‐5D‐5L is a quality of life scale that is responsive for chronic
low back pain patients (Soer, Reneman, Speijer, Coppes, & Vroomen,2012). The EQ‐5D‐5L has five health dimensions: mobility, self‐care,
daily activities, pain/discomfort, and anxiety/depression. Within each
dimension, the patients can self‐rate their level of severity; no, slight,
moderate, severe problems, unable to perform, or do the task
(Versteegh et al., 2016). For the economic evaluation, the patients'
EQ‐5D‐5L health states will be converted into utility scores ranging
from 0 (“death”) to 1 (“optimal health”) using the Dutch tariff
(Versteegh et al., 2016).
The SF‐12 is a shorter version of the SF‐36 health‐related quality‐
of‐life questionnaire. The SF‐12 has been proven to be a reliable and
valid questionnaire for low back pain (Xuemei et al., 2003). The ques-
tionnaire relates to the analysis of the general functional status of
patients. It consists of 12 questions from the following eight domains:
(a) physical functioning, (b) physical role limitations, (c) emotional role
imitations, (d) social functioning, (e) physical pain, (f) general mental
health, (g) vitality, and (h) general health perception. These eight
domains can be summarized into a physical and psychological main
domain (Xuemei et al., 2003). For the economic evaluation, quality‐
adjusted life years will be calculated by multiplying the patients' time
spent in a certain health state by the respective utility value (i.e., area
under the curve method).
Self‐perceived recovery will be measured using the global per-
ceived effect
The global perceived effect measures a patient's self‐perceived
recovery using a 7‐point scale ranging from “worse than ever” (1) to
“completely recovered” (7). Being recovered will be defined as being
“completely recovered” or “much improved”; other responses will be
defined as not recovered. The test reliability of the global perceived
effect scale is said to be good (Kampera et al., 2010).
Societal and health care costs
Societal costs include costs of the intervention, other health care use,
informal care, unpaid productivity losses, and costs due to absentee-
ism (i.e., sickness absence) and presenteeism (i.e., being less productive
while being at work). Health care costs will only include costs accruing
to the formal Dutch health care sector.
Intervention costs will be microcosted. For this purpose, informa-
tion about the combination therapy will be gathered using a case
report form, including information on patient classification, number
of sessions, discharge, and referral to a network MDT or to the sur-
geon. All other cost categories will be measured using cost question-
naires administered at baseline 2, 4, 6, 9, and 12 months after
randomization. Resource use will be valued in accordance with the
Dutch manual of costing (Hakkaart‐van Roijen, Tan, & Bouwmans,
2010). See Table 1: overview of the data collection.2.4 | Procedure
2.4.1 | Treatment allocation
Randomization will be done by an independent researcher who is not
involved in treatment procedures, using a web‐based randomization
TABLE 1 Overview of the data collection
Outcome measures Baseline 4 weeks 2 months 4 months 6 months 9 months 12 months
Prognostic factors
Patient demographics and prognostic factors X
Primary outcome
Surgery rate X X X X X
Secondary outcomes
Pain leg (NPRS) X X X X X X X
Pain back (NPRS) X X X X X X X
Health‐related quality of life (EQ‐5D‐5L and SF‐12) X X X X X X
RMDQ‐23 X X X X X X
Self‐perceived recovery (GPE) X X X X X
Societal and health care costs (cost questionnaires) X X X X X X
Patient satisfaction, complications, and pain location X X X X X X
Abbreviation: NPRS, numeric pain rating scale; RMDQ, Roland Morris Disability Questionnaires.
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fore, the independent researcher does not have any influence on the
randomization procedure, and the treatment allocation is concealed.
Patients will be randomized at the individual level and in a 1:1 ratio.
We will stratify on duration of complaints (i.e., <6months vs.
≥6months), and we will use one randomization list per hospital. The
randomization key will be safeguarded by an independent researcher.
Patients allocated to the intervention group will be called for an
appointment within 48 hr of randomization and will attend their first
appointment within the first week following randomization.2.4.2 | Combination therapy intervention
While being on the waiting list to receive lumbar disc surgery, inter-
vention group participants will receive the combination therapy. The
combination therapy has two parts (a) MDT and (b) TESIs and is
delivered by teams of pain interventionists and physiotherapists.
The pain interventionist is responsible for the TESIs and the physio-
therapists for the MDT. Prior to receiving the combination therapy,
patients are seen by a pain interventionist who checks for contraindi-
cations for injections and medications including steroid use. During
the same appointment, participants are classified as “centralizers” or
“noncentralizers” using MDT principles, that is, assessment of the
patients' pain pattern responses on repeated movement tests.
Centralizers
Centralizers are defined as patients with centralization (i.e., a clear
change in leg pain location from a more peripheral location towards
a more central location, which lasts after testing staying in neutral)
or directional preference (i.e., a reduction in pain intensity, but not in
location, which lasts after testing staying in neutral). Testing for cen-
tralization is done according to MDT principles as described in the
textbook of McKenzie and May (2003). Searching for centralizationis done during repeated movement testing or sustained positioning
in a certain direction. This direction differs in patients. Centralization
could be found in extension, flexion, side gliding, rotation, or a combi-
nation. While testing, an MDT trained physiotherapist is able to decide
how many repetitions are needed (usually between 10 and 20) and
can add manual force (therapist overpressure or mobilization) if
needed, depending on pain response, during and after testing. The
MDT system appears to have acceptable interrater reliability for clas-
sifying patients with back pain into main/subsyndromes, when applied
by therapists who have completed the credentialing examination, but
unacceptable reliability in other therapists (Garcia et al., 2018).
Sustained positioning is often used with high levels of leg pain and
major movement loss in range of motion testing. If a certain direction
is found to centralize the leg and back pain, that same direction of
exercise or positioning will be used as the initial treatment direction.
Patients are advised to exercise seven to eight times a day (i.e., 10 rep-
etitions of extension in lying eight times per day). In the process of
centralization, patients get postural advice in the direction of centrali-
zation (i.e., if extension is the centralizing direction, patients will be
advised to keep their back in lordosis and avoid flexion movements
for a period of time). As soon as centralization is full and stable, the
physiotherapist trained in MDT will restore full function and most
importantly check for fear avoidance of the restricted movement
direction, as this could be the case after avoiding a certain direction
for a period of time.
Noncentralizers
Noncentralizers are defined as patients with peripheralization (i.e., a
clear change towards a more peripheral leg pain location or an
increase in leg pain) or no effect (i.e., no change in leg pain location
or intensity). The hypothesis is that in these patients, the pain is
a result of the inflammation. Noncentralizers will receive a
transforaminal epidural injection in accordance with the procedure
described below.
6 of 8 MUTUBUKI ET AL.Procedure for the TESIs
The patient lies in prone position. Under fluoroscopic guidance with
contrast medium (Iohexol 240 mg/ml 0.5 cc), a very thin needle will
be placed next to the compressed nerve. The contrast medium is then
used to control if fluid will come to the compressed nerve. After which
a combination of a local anaesthetic (lidocaine 20 mg/ml 0.5 cc) with
an anti‐inflammatory agent (dexamethasone 20 mg/ml 0.5 cc) is
injected. Half an hour after the injection, the pain interventionist
checks the effects of the injection. The duration of pain absence is
dependent on the working of the anti‐inflammatory drug on the
inflammation. Two weeks after the injection, the patient is seen back
by the MDT therapist to check for classification in the described sub-
groups and to decide if a second injection is necessary in shared deci-
sion making with patient and the pain interventionist. If pain reduction
is less than 80%, then usually, a second injection will be administered
with patient consent. A maximum of three injections are given to opti-
mize pain relief.
Following TESIs
After the injections, participants will be reclassified using the same
MDT principles, into four subgroups. The subgroups are as follows:
1. resolved symptoms (i.e., no or irrelevant pain; ≤1 on a 0–10
NPRS);
2. centralizing and significantly less pain (i.e., a pain reduction of ≥2
on a 0–10 NPRS);
3. noncentralizing and significantly less pain (i.e., a pain reduction of
≥2 on a 0–10 NPRS); and
4. noncentralizing with high levels of pain and disability (i.e., a pain
score of ≥8 on a 0–10 NPRS and a disability score of >10 on
the RDMQ‐23).
In the first three subgroups mentioned here, patients will get specific
MDT exercises and advice. These three subgroups will be treated by
an MDT therapist in one to six sessions in on average 4 weeks. If more
sessions are required, patients are referred to accredited MDT thera-
pists within the Rugpoli network. Network therapists are in close con-
tact with the Rugpoli centres and are located all over the Netherlands.
Only the patients in Subgroup 4 will be referred back to the neuro-
surgeon who will assess whether patients still require surgery.
Throughout the combination therapy, there is shared decision making.
2.4.3 | Control intervention
Control group participants will solely be placed on a waiting list and
scheduled to receive lumbar disc surgery if still required. The aim of
surgery is to remove the symptomatic disc herniation by a minimal
unilateral transflaval approach with magnification, with the patient
under general or spinal anaesthesia.
2.4.4 | Use of cointervention
Use of cointerventions by patients is allowed and will be monitored.
Patients will be requested to complete questionnaires in whichmedication usage and any health care utilization is recorded through-
out the follow‐up period.
2.4.5 | Blinding
We will not attempt to blind the patients to the intervention or control
condition, as this is practically impossible in this study due to the
nature of the intervention. The outcomes assessor will not be blinded,
because all outcomes are self‐reported. Treatment providers (i.e., sur-
geons, physiotherapist, and anaesthesiologists) will not be blinded due
the nature of the intervention they will provide to patients.
2.4.6 | Sample size
We expect that 90–95% (93% was used in the sample size calculation)
of the patients in the usual care group will receive surgery, and we
hypothesize that in the combination group, this rate will be reduced
by 30% (or more). To detect this difference of 30% with an alpha of
0.05 (two sided), a power of 95%, anticipating a 20% drop‐out rate
and taking into account the multilevel structure (with an Intraclass
Correlation Coefficient (ICC) of 0.15), we need to include a total of
146 patients (n = 73 per treatment group; Pocock, 1983; Twisk,
2006). Even though participants will not be randomized at the hospital
level, the multilevel structure of the data was accounted for in the
sample size calculation, because patients are recruited from different
hospitals (i.e., patients recruited from one hospital are likely to be
more similar than those recruited from other hospitals) and clusters
will likely not be balanced.
2.4.7 | Statistical/data analysis
Baseline characteristics of the patients in both study groups will be pre-
sented using descriptive statistics (mean [standard deviation], median
[range], or proportion) to assess if balanced groups were obtained
after randomization (i.e., having an equal distribution of the main
outcomemeasures, prognostic factors, and known confounding factors
such as age, gender, educational level, and treatment expectation).
2.4.8 | Primary outcome analysis
The primary analysis will be an intention‐to‐treat analysis. The primary
study parameter (i.e., surgery; yes/no) will be analysed in a logistic
mixed model with responses at 2, 4, 6, 9, and 12 months. In this anal-
ysis, we will take into account the levels of hospital, patient, and time
of measurement. An odds ratio with 95% confidence interval between
the combination therapy group and usual care group will be calculated.
If necessary, the analysis will be adjusted for important prognostic
characteristics.
2.4.9 | Secondary outcome analysis
The secondary study parameters (back pain, leg pain, self‐perceived
recovery, health‐related quality of life, and functional status) will be
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gery). However, for continuous outcomes, we will use a linear mixed
model with the same multilevel structure.2.4.10 | Economic evaluation
An economic evaluation will be performed from a societal and a health
care perspective. When the societal perspective is applied, all costs
and consequences relevant to the intervention will be taken into
account irrespective of whom pays or benefits, whereas only those
accruing to the formal Dutch health care sector will be considered
when the health care perspective is applied (Hakkaart‐van Roijen,
van der Linden, Bouwmans, Kanters, & Tan, 2015; Brouwer, van Exel,
Baltussen, & Rutten, 2006).
The economic evaluation will be performed in accordance with the
intention‐to‐treat principle and in terms of quality‐adjusted life years
as well as the primary outcome proportion of LRS patients undergoing
lumbar disc surgery during 12‐month follow‐up. Missing data will be
imputed using multiple imputations by chained equations. The
imputation model will be constructed in accordance with the recom-
mendations of White, Royston, and Wood (2011). Imputed datasets
will be analysed as specified below, after which pooled estimates will
be estimated using Rubin's rules (White et al., 2011). Incremental
cost‐effectiveness ratios will be calculated by dividing the difference
in costs by that in effects. In order to account for the possible cluster-
ing of data, analyses will be performed using linear mixed models
(Gomes et al., 2012). Accounting for the possible clustering of data
(e.g., at the hospital level) is very important, as most economic evalu-
ations fail to do so, whereas ignoring the possible clustering of data
might lead to inaccurate levels of uncertainty and inaccurate point
estimates (Gomes et al., 2012). Bootstrapping techniques will be used
to estimate the uncertainty surrounding the cost‐effectiveness esti-
mates. Uncertainty will be shown by plotting cost‐effect pairs on
cost‐effectiveness planes and by constructing cost‐effectiveness
acceptability curves (Black, 1990; Drummond, Sculpher, Torrance,
O'Brien, & Stoddart, 2005; Fenwick, O'Brien, & Briggs, 2004).
Cost‐effectiveness acceptability curves indicate the probability of an
intervention being cost‐effective compared with a control for a range
of ceiling ratios (i.e., the maximum amount of money decision makers
are willing to pay per unit of effect gained).
Various one‐way sensitivity analyses will be performed to test the
robustness of the study results (e.g., complete‐case analysis and per‐
protocol analysis).3 | DISCUSSION
Prior to this study, only our pilot study has evaluated the effectiveness
of a combination therapy (MDT and TESIs) in patients presenting with
lumbar disc herniation (van Helvoirt et al., 2014). The pilot study indi-
cated the importance of a multidisciplinary approach, which addresses
the inflammatory and mechanical contributors to spine mediated pain,
and has the potential to reduce the numbers of herniated disc surgery.However, the cost‐effectiveness of the combination therapy was not
explored. The results of the pilot study should be interpreted with
great caution because of lack of a control group.
The importance of this study is further emphasized by the fact that
there are huge discrepancies in the treatment and management of
lumbar disc herniation regionally and internationally (Weinstein et al.,
2006). In addition, a lot of costs and burden to society have been asso-
ciated with LRS (Health Council of the Netherlands, 1999). Therefore,
the combination therapy may benefit not only individual patients but
also society as a whole.
To our knowledge, this is the first randomized controlled trial
investigating the effectiveness and cost‐effectiveness of the combina-
tion therapy in patients with LRS compared with usual care. Therefore,
the present study aims to determine if a combination therapy, while
being on the waiting list for a lumbar herniated disc surgery, is effec-
tive and cost‐effective compared with usual care among patients with
an indication for a lumbar herniated disc surgery. Hence, this research
will help bridge the knowledge gap in the treatment and management
of patients with LRS.
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